Clinical characteristics of patients with sustained and reversible no reflow
| Sustained no reflow (n=7) | Reversible no reflow (n=9) | p Value | |
|---|---|---|---|
| *Mean (SD) | |||
| Sex (male) | 6 (85.7%) | 6 (66.6%) | NS |
| Age (years) | 62 (8)* | 60 (10)* | NS |
| Thrombolysis | 5 (71.4%) | 5 (55.5%) | NS |
| Stenosis post-thrombolysis (%) | 61 (17)* | 65 (5)* | NS |
| PTCA | 2 (28.6%) | 4 (44.5%) | NS |
| TIMI grade 3 | 2 (29%) | 5 (55%) | NS |
| Anterior myocardial infarction | 5 (71.4%) | 8 (88.8%) | NS |
| Smoking | 5 (71.4%) | 6 (66.6%) | NS |
| Hypercholesterolaemia | 5 (71.4%) | 6 (66.6%) | NS |
| Hypertension | 4 (57.1%) | 6 (66.6%) | NS |
| Diabetes | 3 (42.8%) | 0 (0%) | NS |
| Prior angina | 2 (28.5%) | 4 (44.4%) | NS |
| Time to reperfusion (hours) | 3.3 (1.5)* | 3.1 (1.5)* | NS |
| Peak creatine kinase (IU/l) | 4846.0 (2735.6)* | 2865.4 (1721.9)* | NS |